This page will track the quarterly sales of Imbruvica over time, as reported by AbbVie over time.

 

Note: Janssen and AbbVie co-market Imbruvica in the United States. Janssen markets it in EMEA (Europe, Middle East and Africa) and rest of the world. The companies share profits 50/50. The below figures represent sales only as reported by AbbView during its quarterly earnings reports. It includes both U.S. sales and rest-of-world royalties.